Physician

Cardiology

Dr. Angel K. Markov, MD

Angel Markov is an expert in the field of Cardiology. He received 1 awards: "Fellow (FACC)". Doctor Angel K. Markov, MD has written publications. He has 41 publications published with PubMed. The lastest paper is: 'Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs.' Angel Markov accepts all Medicare patients.

Publications

Observations on the use of the aVR-V6 relationship to recognize limb lead error.
Influence of fructose-1,6-diphosphate on endotoxin-induced lung injuries in sheep.
Einthoven's triangle: lead errors and an algorithm for solution.
Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, 6, beta-actin mRNAs, and transcription factors expression.
Fructose diphosphate attenuates the acetaminophen-induced liver injury in the rat evidence for involvement of nitric oxide.
Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 ...
Prevention of alpha-naphthylthiourea-induced Pulmonary edema with fructose-1,6-diphosphate.
The effects of fructose-1,6-diphosphate on the isolated rabbit Heart.
Myocardial K+ loss after countershcok and the relation to ventricular Arrhythmias after nontoxic doses of acetyl strophanthidin.
Therapeutic action of fructose-1,6-diphosphate in traumatic shock.
Myocardial ion and lipid changes during ischemia and catecholamine induced necrosis: Relation to regional blood flow.
Cerebral resuscitation with succinate and fructose-1, 6-diphosphate.
Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate.
Irreversible hemorrhagic shock: treatment and cardiac pathophysiology.
Fructose-1,6-bisphosphate, when given immediately before reoxygenation, or before injury, does not ameliorate hypoxic ischemic injury to the central nervous system in ...
Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on Acute myocardial ischemia.
Changes in the cardiovascular nitric oxide pathway in cyclosporin-A treated rats.
Fructose 1-6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats.
Improved brain metabolism with fructose 1-6 diphosphate during insulin-induced hypoglycemic coma.
Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations.
Fructose-1,6-diphosphate, when given five minutes after injury, does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig.
Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.
Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat.
Increasing survival of dogs subjected to hemorrhagic shock by administration of fructose 1-6 diphosphate.
Protective effects of misoprostol on carbon tetrachloride-induced liver damage in the rat.
Stimulating effect of fructose 1-6 diphosphate on the phagocytic function of rat RES and on human leukocyte carbohydrate metabolism.
In vitro inhibition of rat Heart sarcoplasmic reticular membrane ATPase activities by amphotericin B and their reversal by fructose-1,6-diphosphate.
Plasma oxidase assay for screening of Myocardial infarction.
In vitro induction of nitric oxide by fructose-1,6-diphosphate in the cardiovascular system of rats.
Attenuation of ischemic renal injury with fructose 1,6-diphosphate.
Metabolic responses to fructose-1,6-diphosphate in healthy subjects.
Protection from amphotericin B-induced lipid peroxidation in rats by fructose-1,6-diphosphate.
Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs.
Myocardial toxicity of cyclosporin A: inhibition of calcium ATPase and nitric oxide synthase activities and attenuation by fructose-1,6-diphosphate in vitro.
Prevention of galactosamine-induced hepatotoxicity in rats with fructose-1,6-diphosphate.
The role of fructose-1,6-diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing.
Effect of fructose-1, 6-diphosphate versus diphenhydramine on mortality in compound 48/80-induced shock.
Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function.
Effects of fructose-1,6-diphosphate on the activity of rat liver nitric oxide synthase in vitro.
Osborn (J) wave appearance on the electrocardiogram in relation to potassium transfer and Myocardial metabolism during hypothermia.

Conditions Treated

Angina and Acute Coronary Syndrome
Aortic Aneurysm
Aortic Valve Disease
Arrhythmias (incl. Atrial Fibrillation)
View All

Doctors Specialties

Cardiology

Accepted Insurances

Awards

Fellow (FACC)

Education

University of Mississippi Medical Center
Catholic University of Leuven

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1104848282
Last Name Of The Provider	MARKOV
First Name Of The Provider	ANGEL
View All

Similar Doctors

	Dr. Matthew D. Deshazo, MD This Doctor is OpenDoctor Recommended.
	Dr. Malcolm P. Taylor, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith D. Thorne, MD This Doctor is OpenDoctor Recommended.
	Dr. D Russell Young, MD
	Dr. James L. Warnock Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Sushant S. Khaire, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard D. Ballard, MD
	Dr. John P. Payne, MD
	Dr. John A. Bellan, MD This Doctor is OpenDoctor Recommended.
	Dr. Ernest M. Quin, MD This Doctor is OpenDoctor Recommended.
	Dr. H Chris Waterer III, MD
	Dr. Carlos E. Drago, MD